Last week, the U.S. Food and Drug Administration (FDA) approved the gene drug Kymriah for certain types of cancer. However, Kymriah costs $475,000 for...
On June 22, Bitcoin Magazinereported that Antshares was embarking on a new rebranding strategy as part of its effort to lead blockchain development in...
This is a sponsored article provided by the Blockchain Global Summit.On September 10, Beijing, China will welcome a prominent gathering of cryptocurrency and blockchain...
On May 12, 2017, Chinese blockchain technology leader Wanxiang Group, a conglomerate with automotive, real estate and financial services holdings, announced the launch of...
Across China, blockchain technology is recognized as an increasingly important development; however, bitcoin as a “virtual good” in China is facing yet another challenge...